Aristotle University Of Thessaloniki (AUTH)
Προγνωστική σημασία της παρουσίας μεταλλάξεων στα γονίδια IDH1, H3F3, ATRX, CIC, FUBP1 και TERT σε γλοιώματα υψηλού βαθμού κακοήθειας
Abstract
dc:descriptionIntroduction: High grade glioma molecular profiling is of particular interest in neurooncology. The aim of this PhD thesis is to investigate the possibility of separating prognostic groups of patients with high grade gliomas based on mutation patterns in IDH1, H3F3, ATRX,CIC, FUBP1 and TERT genes.Methods:178 patients with a diagnosis of high-grade malignancy glioma were included in 2 cohorts. 126 patients were enrolled in cohort 1and a total of 101 paraffin blocks from these patients were analyzed. A further 52 new patients were enrolled in cohort 2 and these 52 new patients alongside 98 patients from cohort 1 from which paraffin blocks were available for further analysis consist cohort 2. Unfortunately in cohort 2 only 48 paraffin blocks were suitable for further analysis and from these 48 blocks at the end 32 were analysed. In cohort 1, tumor genotyping was performed with a 55 gene NGS panel. TERT mutations were tested with Sanger sequencing. MGMT promoter methylation status was determined by methylation specific PCR. In cohort 2 a broad pan cancer 80 gene NGS panel was used for tumor genotyping. 14 of 32 tumor specimens were also genotyped using the 55 gene NGS panel for diagnostic accuracy validation and clinical utility of the extended panel.Results:Cohort 1. 270 mutations were detected in 92/101 tumors (91.1%). TERT was the most frequently mutated gene (74.3%). IDH1/2 mutations were mutually exclusive with mutations in the neurofibromin 1 (NF1) gene. Mutated TERT was associated with wild-type (wt) IDH1/2 (p = 0.025). The 12-month overall survival (OS) rate was 74.3%. Patients with TERT and NF1 wt had a median OS of 40.8 months, while among pts with NF1 wt/TERT mutant, the median OS was 18.5 months. NF1 and TERT mutations univariately conferred shorter OS (HR = 3.19; p = 0.004 and HR = 2.28; p = 0.002). Upon multivariate analysis, mutated TERT showed marginal unfavorable prognostic significance for OS (p = 0.049), while NF1 lost its unfavorable significance (p = 0.151). Cohort 2. In total, 129 genetic alterations including 33 structural variants were identified in 38 distinct genes. Among 96 variants, 38 were pathogenic and 58 variants of unknown clinical significance (VUS). TP53 was the most frequently mutated gene, followed by PTEN and IDH1genes. Glioma patients with IDH1 mutant tumors were younger and had significantly longer overall survival compared to patients with wild-type IDH1tumors. Similarly, tumors with TP53mutations were more likely observed in younger glioma patients. Implementation of the comprehensive 80 gene and the55 gene panels resulted in the identification of 37 and 15 variants, respectively. Of those, 13 were common. Comprehensive 80 gene panel identified 24 additional variants, 22 of which located in regions that were not targeted by the 55 gene panel. On the contrary, the latter panel identified two additional variants.Conclusions: TERT is herein proven to confer poor prognosis in high grade gliomas, independent of IDH and MGMT mutations. NF1 seems to also confer poor prognosis although our small numbers do not allow for firm conclusions. Overall, our data show that using an extended tumor profile assay rather than a glioma-specific tumor profile panel identifies additional genetic changes that may be taken into consideration as potential therapeutic targets for glioma diagnosis and molecular classification.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Romanidou, Ourania
- Ρωμανίδου, Ουρανία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53250